Root Financial Partners’s Cartesian Therapeutics RNAC Stock Holding History
Bought
Maintained
Sold
Other funds holding RNAC
6CM
Root Financial Partners's RNAC Position: Q3 2026 in Review
Root Financial Partners opened a new position in Cartesian Therapeutics (RNAC) in Q3 2026: 61 shares worth $440. The stake represents ﹤0.01% of the portfolio and ranks #3266 among its holdings. This is a return to the name: Root Financial Partners previously reported a position in RNAC as recently as Q1 2026.
Root Financial Partners first reported a position in RNAC in Q1 2026 and has held it in 2 quarters since. 99 funds tracked by Wall St. Rank hold RNAC as of Q3 2026.
- Root Financial Partners held 61 shares of Cartesian Therapeutics worth $440 as of Q3 2026.
- Cartesian Therapeutics was a new Root Financial Partners position in Q3 2026.
- Cartesian Therapeutics made up ﹤0.01% of Root Financial Partners's portfolio in Q3 2026, its #3266 holding.
- Root Financial Partners first reported a position in Cartesian Therapeutics in Q1 2026 and has held it in 2 quarters since.
- 99 funds tracked by Wall St. Rank held Cartesian Therapeutics as of Q3 2026.
Based on Root Financial Partners's 13F filing for Q3 2026, filed 21 Oct 2026.